原发性肝癌经肝动脉化疗栓塞术前使用静脉持续泵入恩度治疗的临床疗效 Evaluation on the Clinical Effect of Endostar by Continuous Intravenous Infusion in the Treatment of Patients with Primary Carcinoma of Liver Before the TACE Operation
马继恒,华海清,戴婷婷,等.消癌平与奥沙利铂及恩度联合对人肝癌细胞株SMMC-7721的体外增殖抑制实验[J].世界华人消化杂志,2014,22(29):4 461-4 466.Ma JH,Hua HQ,Dai TT,et al.Effect of Xiaoaiping,oxaliplatin and Endostar,alone or in combination,on cell proliferation in human hepatoma cell line SMMC-7721[J].World Chinese Journal of Digestology,2014,22(29):4 461-4 466.
[2]
林清,张少言,黄念,等.重组人血管内皮抑素注射液联合经肝动脉化疗栓塞治疗原发性肝癌的Meta分析[J].世界华人消化杂志,2015,23(4):655-664.Lin Q,Zhang SY,Huang,et al.Intrahepatic arterial infusion of endostatin combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma:a meta-analysis[J].World Chinese Journal of Digestology,2015,23(4):655-664.
[3]
Facciorusso A,Bellanti F,Villani R,et al.Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma:A meta-analysis of randomized trials[J].United European Gastroenterol J,2017,5(4):511-518.
[4]
Daniele A,Abbate I,Oakley C,et al.Clinical and prognostic role of matrix metalloproteinase-2,-9and their inhibitors in breast cancer and liver diseases:A review[J].Int J Biochem Cell Biol,2016,77(Pt A):91-101.
[5]
张弢,段学章,张军华,等.重组人血管内皮抑制素(恩度)联合肝动脉栓塞化疗术(TACE)治疗中晚期肝癌的临床疗效评价[J].现代生物医学进展,2014,27(34):6 664-6 666.Zhang T,Duan XZ,Zhang JH,et al.The clinical efficacy of recombinant human endostatin(En Du)combined with transcatheter arterial chemoembolization(TACE)in the treatment of medium and advanced liver cancer[J].Progress in Modern Biomedicine,2014,27(34):6 664-6 666.
[6]
方蕾,赵展,吴乾能,等.恩度联合TACE术治疗肝癌对患者血清VEGF、HIF-1A、OPN、MMP-9的影响及意义[J].中华全科医学,2016,14(3):412-414.Fang L,Zhao Z,Wu QN,et al.Influence and significance of hepatic transcatheter arterial chemoembolization combime with endostar on levels of serum VEGF,HIF-1A,OPN and MMP-9in patients with hepatocellular carcinoma[J].Applied Journal of General Practice,2016,14(3):412-414.
[7]
霍亮.化疗栓塞术联合恩度对中晚期肝癌患者实体肿瘤、KPS评分及VEGF水平的影响[J].河南医学研究,2016,25(1):64-65.Huo L.Influence of chemoembolization combined with Endostar for the solid tumor,KPS score and VEGF level of patients with moderate or advanced liver cancer[J].Henan Medical Research,2016,25(1):64-65.
[8]
赵建新,朱晓黎,刘一之,等.肝动脉化疗栓塞联合局部抗血管生成治疗中晚期肝癌的临床研究[J].临床放射学杂志,2014,33(1):113-117.Zhao JX,Zhu XL,Liu YZ,et al.Transcatheter hepatic arterial chemoembolization combined with local antiangiogenic therapy in advanced hepatocellular carcinoma[J].Journal of Clinical Radiology,2014,33(1):113-117.
[9]
朱应合,周俭,薛忠,等.化疗药物+恩度碘油乳剂经肝动脉栓塞治疗肝癌的临床效果[J].江苏医药,2013,39(6):677-679.Zhu YH,Zhou J,Xue Z,et al.Efficacy of transcatheter arterial chemoembolization with chemotherapeutics combined with endostar-iodized oil emulsion in treating advanced hepatocellular carcinoma[J].Jiangsu Medical Journal,2013,39(6):677-679.
[10]
Fong ZV,Tanabe KK.The clinical management of hepatocellular carcinoma in the United States,Europe,and Asia:a comprehensive and evidence-based comparison and review[J].Cancer,2014,120(18):2 824-2 838.
郭宇玲,游震宇,李勇,等.恩度联合化疗治疗晚期原发性肝癌的临床研究[J].江西医药,2013,48(12):1 166-1 168.Guo YL,You ZY,Li Y,et al.Clinical study on the endostar combined with chemotherapy in the treatment of patients with advanced primary liver cancer[J].Jiangxi Medical Journal,2013,48(12):1 166-1 168.
[13]
孙涛,周立群,李艳花.恩度联合介入治疗对肝癌血管生成抑制作用的研究[J].现代肿瘤医学,2013,21(1):122-123.Sun T,Zhou LQ,Li YH.Effect of endostar combined with TACE on vascular growth of hepatocellalar carcinoma[J].Journal of Modern Oncology,2013,21(1):122-123.
[14]
苗玉永.恩度联合TACE术对肝癌患者血清VEGF、CTGF、OPN、MMP-9的影响[J].中国中西医结合消化杂志,2017,25(3):202-205.Miao YY.Influence of hepatictranscatheter arterial chemoembolization combimed with endostar on levels of serum VEGF,CTGF,OPN and MMP-9in patients with hepatocellular carcinoma[J].Chinese Journal of Integrated Traditional and Western Medicine on Digestion,2017,25(3):202-205.
[15]
曾勇,程朋,官泳松.恩度联合动脉灌注化疗栓塞(TACE)治疗后原发性肝癌恶性程度的评估[J].海南医学院学报,2016,22(8):799-802.Zeng Y,Cheng P,Guan YS.Evaluation of malignant degree of primary hepatocellular carcinoma after endostar combined with transcatheter arterial chemoembolization(TACE)treatment[J].Journal of Hainan Medical College,2016,22(8):799-802.
[16]
潘海燕,关晓东,张百萌.转移性结直肠癌XELOX与FLOFOX6治疗方案的临床疗效与毒副反应观察[J].胃肠病学和肝病学杂志,2016,25(2):144-147.Pan HY,Guan XD,Zhang BM.Clinical effect and toxicity observation of XELOX and FLOFOX6in treatment of metastatic colorectal cancer[J].Chinese Journal of Gastroenterology and Hepatology,2016,25(2):144-147.
[17]
谢华英,陈海燕,徐欣,等.恩度联合TACE治疗对原发性肝癌患者的有效性及安全性的Meta分析[J].实用癌症杂志,2016,31(9):1 507-1 511.Xie HY,Chen HY,Xu X,et al.Efficacy and safety of endostatin combined with TACE for hepatocellular carcinoma:a meta-analysis[J].The Practical Journal of Cancer,2016,31(9):1 507-1 511.
[18]
李丽娜,南克俊,徐瑞.恩度联合吉西他滨对肝癌HepG2细胞的抑制作用及对HIF-1α、VEGF表达的影响[J].现代肿瘤医学,2013,21(8):1 703-1 707.Li LN,Nan KJ,Xu R.The effect of endostar combined with gemcitabine on the inhibition and the expression of HIF-1αand VEGF of HepG2cells[J].Journal of Modern Oncology,2013,21(8):1 703-1 707.
[19]
刘琪,武振明,齐秀恒,等.恩度肝动脉灌注联合肝动脉化疗栓塞治疗中晚期原发性肝癌的生存分析[J].临床肝胆病杂志,2015,31(2):225-227.Liu Q,Wu ZM,Qi XH,et al.Survival analysis of intrahepatic arterial infusion of Endostar combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma[J].Chinese Journal of Clinical Hepatology,2015,31(2):225-227.
